Clearside Biomedical Inc

NASDAQ:CLSD  
1.34
0.00 (0.00%)
Earnings Announcements

Clearside Biomedical Announces First Quarter 2022 Financial Results

Published: 05/11/2022 20:47 GMT
Clearside Biomedical Inc (CLSD) - Clearside Biomedical Announces First Quarter 2022 Financial Results and Provides Corporate Update.
Clearside Biomedical - Believes It Will Have Sufficient Resources to Fund Its Planned Operations for at Least Next Twelve Months.
Qtrly Net Loss per Share of Common Stock Basic and Diluted $0.13.
Q1 Earnings per Share View $-0.08 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $5.44 Million
Adjusted EPS is expected to be -$0.08

Next Quarter Revenue Guidance is expected to be $0.71 Million
Next Quarter EPS Guidance is expected to be -$0.12

More details on our Analysts Page.